Complete the Standard 3-Dose Hepatitis B Vaccine Series
For a college student with only one prior dose and a negative anti-HBs titer, administer the remaining two doses of hepatitis B vaccine to complete a standard 3-dose series (doses at months 0,1, and 6), counting the previous dose as dose #1. 1
Rationale and Approach
The ACIP guidelines are clear: if the hepatitis B vaccination schedule is interrupted, the series does not need to be restarted 1. Since this student received one dose previously, you should:
- Count that previous dose as dose #1 (regardless of when it was given)
- Administer dose #2 immediately
- Administer dose #3 at least 8 weeks after dose #2 and at least 16 weeks after dose #1 1
The minimum interval between doses 1 and 2 is 4 weeks, and the final dose must be given ≥8 weeks after the second dose and ≥16 weeks after the first dose 1.
Why Not Just Give a Single Booster?
The negative titer indicates this student never achieved initial immunity from that single dose—this is fundamentally different from someone who was previously immune but has waning antibodies. Recent research confirms that among college students with negative anti-HBs, 98.5% achieved protective seroconversion after two doses, and 100% after three doses 2. A single challenge dose strategy is appropriate for those who were previously immune, not for those who never seroconverted initially.
Vaccine Selection for College Students
For adults ≥18 years, you have several options 1:
- Recombivax HB: 10 μg (1 mL) at months 0,1,6
- Engerix-B: 20 μg (1 mL) at months 0,1,6
- Heplisav-B: 20 μg (0.5 mL) at months 0,1 (2-dose series)
- PreHevbrio: 10 μg (1 mL) at months 0,1,6
Heplisav-B offers a practical advantage with only 2 doses separated by 1 month, which may improve compliance for busy college students, though you would need to restart the series since the previous dose was likely a different formulation.
Post-Vaccination Testing
Do not recheck titers after completing the series unless the student will be in a high-risk healthcare role (exposure-prone procedures). Research shows that among healthcare students who completed revaccination, only 2% remained true non-responders 3. Testing too early or unnecessarily increases costs (>$20,000 for one cohort) and delays college entry 3.
Common Pitfalls to Avoid
- Don't restart the series unnecessarily—interrupted schedules can be continued 1
- Don't give just one "booster" dose—this student needs a complete primary series since they never achieved immunity
- Don't delay college entry for testing—complete the vaccination series first; testing is not required for college admission unless specifically mandated for healthcare programs 1
- Don't assume non-response prematurely—true non-responders are rare (0.1-2%) after a complete series 2, 4